For expensive drugs such as glucagon-like peptide 1 receptor agonists (GLP-1s), payer coverage is crucial for patient affordability
Target at least 0.7-1.0 grams of protein per pound of goal body weight daily
Tirzepatide carries warnings for thyroid C-cell tumors (based on rodent studies), acute pancreatitis, gallbladder disease, acute kidney injury, severe gastrointestinal disease, and diabetic retinopathy complications
Mild nausea, constipation, and appetite loss are most common during weeks 1-4 of treatment and typically resolve as your body adjusts
349,350 Novel cellular processes and pharmacological targets Although many studies have verified the molecular mechanisms and related drug targets involved in the process of UC occurrence and development, many new insights have been proposed into the pathogenesis of UC in recent years